$AVDL
AVADEL PHARMACEUTICALS PLC

2022 Q4 Form 10-Q Financial Statement

#000101247722000014 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $16.98M $14.10M
YoY Change -19.24% -33.77%
% of Gross Profit
Research & Development $6.235M $2.933M
YoY Change 195.5% -33.04%
% of Gross Profit
Depreciation & Amortization $586.0K $401.0K
YoY Change 191.54% 103.55%
% of Gross Profit
Operating Expenses $23.22M $17.03M
YoY Change 0.35% -33.64%
Operating Profit -$16.96M
YoY Change -33.91%
Interest Expense -$3.255M -$3.564M
YoY Change -21.64% 84.76%
% of Operating Profit
Other Income/Expense, Net -$1.072M $448.0K
YoY Change -265.94%
Pretax Income -$27.37M -$20.08M
YoY Change 2.71% -25.93%
Income Tax $85.00K $70.00K
% Of Pretax Income
Net Earnings -$27.45M -$20.15M
YoY Change 23.09% -8.44%
Net Earnings / Revenue
Basic Earnings Per Share -$0.33
Diluted Earnings Per Share -$0.44 -$0.33
COMMON SHARES
Basic Shares Outstanding 61.78M shares 59.79M shares
Diluted Shares Outstanding 60.20M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.50M $106.5M
YoY Change -38.62% -41.2%
Cash & Equivalents $73.98M $60.72M
Short-Term Investments $22.52M $45.76M
Other Short-Term Assets $228.0K $567.0K
YoY Change -15.87% 48.43%
Inventory $0.00
Prepaid Expenses $1.523M $3.745M
Receivables $276.0K $277.0K
Other Receivables $2.317M $2.158M
Total Short-Term Assets $100.8M $113.2M
YoY Change -47.61% -44.99%
LONG-TERM ASSETS
Property, Plant & Equipment $839.0K $896.0K
YoY Change 194.39% 194.74%
Goodwill $16.84M $16.84M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.32M $11.72M
YoY Change -66.48% -69.24%
Total Long-Term Assets $31.94M $32.54M
YoY Change -41.69% -44.16%
TOTAL ASSETS
Total Short-Term Assets $100.8M $113.2M
Total Long-Term Assets $31.94M $32.54M
Total Assets $132.8M $145.8M
YoY Change -46.3% -44.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.890M $2.479M
YoY Change 2.75% -63.94%
Accrued Expenses $7.334M $7.965M
YoY Change 2.56% -8.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $37.67M $26.30M
YoY Change
Total Short-Term Liabilities $55.79M $41.51M
YoY Change 165.68% 136.03%
LONG-TERM LIABILITIES
Long-Term Debt $91.61M $109.9M
YoY Change -35.66% -22.63%
Other Long-Term Liabilities $5.743M $5.727M
YoY Change 46.62% 43.21%
Total Long-Term Liabilities $97.36M $115.7M
YoY Change -33.46% -20.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.79M $41.51M
Total Long-Term Liabilities $97.36M $115.7M
Total Liabilities $153.9M $158.2M
YoY Change -8.93% -4.2%
SHAREHOLDERS EQUITY
Retained Earnings -$585.2M -$557.8M
YoY Change 30.7% 31.1%
Common Stock $590.4M $573.2M
YoY Change 7.36% 4.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.15M -$12.44M
YoY Change
Total Liabilities & Shareholders Equity $132.8M $145.8M
YoY Change -46.3% -44.81%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$27.45M -$20.15M
YoY Change 23.09% -8.44%
Depreciation, Depletion And Amortization $586.0K $401.0K
YoY Change 191.54% 103.55%
Cash From Operating Activities -$15.37M -$6.803M
YoY Change -31.72% -67.97%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$716.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $22.88M $3.240M
YoY Change 49.31% -73.65%
Cash From Investing Activities $22.87M $2.524M
YoY Change 49.31% -79.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.622M 10.72M
YoY Change 9299.12%
NET CHANGE
Cash From Operating Activities -15.37M -6.803M
Cash From Investing Activities 22.87M 2.524M
Cash From Financing Activities 6.622M 10.72M
Net Change In Cash 14.13M 6.436M
YoY Change -296.65% -172.89%
FREE CASH FLOW
Cash From Operating Activities -$15.37M -$6.803M
Capital Expenditures $0.00 -$716.0K
Free Cash Flow -$15.37M -$6.087M
YoY Change -31.72% -71.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001012477
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37977
dei Entity Registrant Name
EntityRegistrantName
AVADEL PHARMACEUTICALS PLC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1341933
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Earlsfort Terrace
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 2
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D02 T380
dei Entity Address Country
EntityAddressCountry
IE
dei Country Region
CountryRegion
353
dei City Area Code
CityAreaCode
1
dei Local Phone Number
LocalPhoneNumber
901-5201
dei Security12b Title
Security12bTitle
Ordinary Shares, nominal value $0.01 per share**
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
74000 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61778732 shares
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2933000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4380000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14465000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14994000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14096000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21283000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57535000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47469000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
-69000 usd
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
3523000 usd
us-gaap Restructuring Charges
RestructuringCharges
-53000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
16960000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
25663000 usd
us-gaap Costs And Expenses
CostsAndExpenses
75523000 usd
us-gaap Costs And Expenses
CostsAndExpenses
62410000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16960000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25663000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-75523000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-62410000 usd
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
448000 usd
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
489000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
503000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
1531000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3564000 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1929000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
9087000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
5788000 usd
CY2022Q3 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
0 usd
CY2021Q3 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
0 usd
us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
33000 usd
us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
166000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20076000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27103000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84074000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66501000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5101000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25940000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11473000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-20146000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-110014000 usd
us-gaap Net Income Loss
NetIncomeLoss
-55028000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60201000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58585000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59359000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58506000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60201000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58585000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59359000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58506000 shares
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
1092000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-20146000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-110014000 usd
us-gaap Net Income Loss
NetIncomeLoss
-55028000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-647000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-237000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1489000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-839000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-59000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-220000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-934000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-157000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2480000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-854000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1581000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-394000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3969000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1693000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21727000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22396000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-113983000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-56721000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60715000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50708000 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
45760000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
106513000 usd
CY2022Q3 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
2077000 usd
CY2021Q4 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
2443000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4670000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32826000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
113222000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
192490000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
896000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1947000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2652000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
16836000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
16836000 usd
CY2022Q3 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
1137000 usd
CY2021Q4 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
1225000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11720000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33777000 usd
CY2022Q3 us-gaap Assets
Assets
145758000 usd
CY2021Q4 us-gaap Assets
Assets
247265000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
26299000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1011000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
900000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2479000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7679000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7965000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7151000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3757000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5270000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41511000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21000000 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
109934000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
142397000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1026000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1707000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5727000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3917000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
158198000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
169021000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
488000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
488000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
488000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
488000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
5000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60885000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60885000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58620000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58620000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
608000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
586000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
572626000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
549349000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-557770000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447756000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27909000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23940000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12440000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
78244000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145758000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
247265000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
78244000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26424000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1102000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1906000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
103000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2505000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
55232000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-63444000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1286000 usd
CY2022Q2 avdl Adjustments To Additional Paid In Capital Adjustments In Fair Value Of Convertible Debt Conversion Feature
AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature
5508000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
658000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3332000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-20146000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1581000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
64000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10532000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
19000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
119000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1923000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12440000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
162266000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13445000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1255000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
106000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
43000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1728000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
136504000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19581000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2001000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
118880000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22002000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-394000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
51000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2359000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
98957000 usd
us-gaap Net Income Loss
NetIncomeLoss
-110014000 usd
us-gaap Net Income Loss
NetIncomeLoss
-55028000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
907000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
614000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4147000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
937000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
25916000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11322000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5086000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6088000 usd
us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
33000 usd
us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
166000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1539000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1056000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27948000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
54000 usd
avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-27000 usd
avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-3079000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11629000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-201000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4277000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2421000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3109000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
2228000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54938000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54804000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
716000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
16500000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
59873000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
83726000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2334000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
58591000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
56823000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
41609000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4803000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10532000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2192000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
263000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7921000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
263000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-621000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10007000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13553000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50708000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71722000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60715000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58169000 usd
us-gaap Interest Paid Net
InterestPaidNet
9660000 usd
us-gaap Interest Paid Net
InterestPaidNet
6469000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-32323000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
173000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
68000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60715000 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
45760000 usd
CY2020Q1 avdl Sale Of Stock Commission Percentage
SaleOfStockCommissionPercentage
0.030
CY2021Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
66000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
372000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48325000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
220000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2785000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
45760000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
106812000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
948000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1247000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
106513000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
64000 usd
CY2021Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
22000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
61000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
8371000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
520000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
5908000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
604000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
14279000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1124000 usd
avdl Coupon Interest Expense
CouponInterestExpense
4851000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4147000 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
76000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
26299000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
109934000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
142397000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3564000 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1929000 usd
CY2022Q3 avdl Coupon Interest Expense
CouponInterestExpense
1646000 usd
CY2021Q3 avdl Coupon Interest Expense
CouponInterestExpense
1617000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1918000 usd
CY2021Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
312000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
9087000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
5788000 usd
avdl Coupon Interest Expense
CouponInterestExpense
4852000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
937000 usd
avdl Additional Interest Expense Debt
AdditionalInterestExpenseDebt
88000 usd
CY2022Q2 avdl Debt Instrument Convertible Embedded Conversion Feature Increase Decrease
DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease
5508000 usd
CY2022Q2 avdl Adjustments To Additional Paid In Capital Adjustments In Fair Value Of Convertible Debt Conversion Feature
AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature
5508000 usd
CY2022Q2 avdl Debt Instrument Convertible Embedded Conversion Feature Increase Decrease
DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease
5508000 usd
CY2018Q1 avdl American Depository Shares Conversion Ratio
AmericanDepositorySharesConversionRatio
92.6956 rate
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
567000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
271000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5101000 usd
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25940000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.309
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11473000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.173
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3745000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3179000 usd
CY2022Q3 avdl Guarantee Current
GuaranteeCurrent
277000 usd
CY2021Q4 avdl Guarantee Current
GuaranteeCurrent
279000 usd
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
81000 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
29097000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4670000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32826000 usd
CY2022Q3 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
10979000 usd
CY2021Q4 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
8549000 usd
CY2022Q3 avdl Guarantee Noncurrent
GuaranteeNoncurrent
564000 usd
CY2021Q4 avdl Guarantee Noncurrent
GuaranteeNoncurrent
771000 usd
CY2022Q3 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
177000 usd
CY2021Q4 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
329000 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
24128000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11720000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33777000 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4419000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2678000 usd
CY2022Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1515000 usd
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
41000 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1293000 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3167000 usd
CY2022Q3 avdl Accrued Outsource Contract Costs
AccruedOutsourceContractCosts
738000 usd
CY2021Q4 avdl Accrued Outsource Contract Costs
AccruedOutsourceContractCosts
1048000 usd
CY2022Q3 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
0 usd
CY2021Q4 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
217000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7965000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7151000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3265000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q3 avdl Other Guarantor Obligations Current Carrying Value
OtherGuarantorObligationsCurrentCarryingValue
278000 usd
CY2021Q4 avdl Other Guarantor Obligations Current Carrying Value
OtherGuarantorObligationsCurrentCarryingValue
280000 usd
CY2022Q3 avdl Accrued Interest Current
AccruedInterestCurrent
199000 usd
CY2021Q4 avdl Accrued Interest Current
AccruedInterestCurrent
4920000 usd
CY2022Q3 avdl Other Liabilities Miscellaneous Current
OtherLiabilitiesMiscellaneousCurrent
15000 usd
CY2021Q4 avdl Other Liabilities Miscellaneous Current
OtherLiabilitiesMiscellaneousCurrent
70000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3757000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5270000 usd
CY2022Q3 avdl Tax Liabilities And Other Noncurrent Liabilities
TaxLiabilitiesAndOtherNoncurrentLiabilities
5161000 usd
CY2021Q4 avdl Tax Liabilities And Other Noncurrent Liabilities
TaxLiabilitiesAndOtherNoncurrentLiabilities
3143000 usd
CY2022Q3 us-gaap Guaranty Liabilities
GuarantyLiabilities
566000 usd
CY2021Q4 us-gaap Guaranty Liabilities
GuarantyLiabilities
774000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5727000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3917000 usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60201000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-20146000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-110014000 usd
us-gaap Net Income Loss
NetIncomeLoss
-55028000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60201000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58585000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59359000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58506000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58585000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59359000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58506000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18722000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15684000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18925000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15497000 shares
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-59000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-220000 usd
avdl Percentage Of Royalty Payable On Net Sales
PercentageOfRoyaltyPayableOnNetSales
0.15
CY2022Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
844000 usd
CY2022Q3 avdl Guarantee Asset Current Carrying Value
GuaranteeAssetCurrentCarryingValue
841000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
-69000 usd
us-gaap Restructuring Charges
RestructuringCharges
3523000 usd
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
avdl Restructuring Charges Excluding Other Adjustments
RestructuringChargesExcludingOtherAdjustments
3592000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
2043000 usd
us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
69000 usd
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
1480000 usd
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
1480000 usd

Files In Submission

Name View Source Status
0001012477-22-000014-index-headers.html Edgar Link pending
0001012477-22-000014-index.html Edgar Link pending
0001012477-22-000014.txt Edgar Link pending
0001012477-22-000014-xbrl.zip Edgar Link pending
avdl-20220930.htm Edgar Link pending
avdl-20220930.xsd Edgar Link pending
exhibit101-divisemployment.htm Edgar Link pending
exhibit102-mchughemploymen.htm Edgar Link pending
exhibit103-kimemploymentag.htm Edgar Link pending
exhibit311q32022.htm Edgar Link pending
exhibit312q32022.htm Edgar Link pending
exhibit321q32022.htm Edgar Link pending
exhibit322q32022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
avdl-20220930_def.xml Edgar Link unprocessable
avdl-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avdl-20220930_pre.xml Edgar Link unprocessable
avdl-20220930_htm.xml Edgar Link completed
avdl-20220930_cal.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending